Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates

Related NEOG
Earnings Scheduled For September 22, 2014
Benzinga Weekly Preview: Eyes On The Middle East As Lawmakers Discuss War On Terror, Nuclear Capabilities
Related ABAX
Stocks Hitting 52-Week Highs
Cerus (CERS) in Focus: Stock Moves 5.9% Higher - Tale of the Tape

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year.

Neogen (NASDAQ: NEOG) is likely to earn $1.30 per share in the next year ending May, 2014. Neogen's PEG ratio is 2.06.

Abaxis (NASDAQ: ABAX) may earn $1.11 per share in the next year ending March, 2014. Abaxis' trailing-twelve-month operating margin is 12.95%.

Trinity Biotech plc (NASDAQ: TRIB) is projected to earn $0.92 per share for the next year ending December, 2013. Trinity Biotech's trailing-twelve-month revenue is $80.67 million.

Meridian Bioscience (NASDAQ: VIVO) is expected to earn $0.88 per share over the next year ending September, 2013. Meridian Bioscience's trailing-twelve-month ROE is 22.58%.

Posted-In: Diagnostic Substances Industry Highest EPS Estimates small-capTrading Ideas

 

Related Articles (ABAX + NEOG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters